This is the authors' abstract. We don't add key points for this paper.
SMs are reliably detected in urinary cpDNA and cfDNA. The technical capability to identify very low MAFs is essential to reliably detect UBC, regardless of the use of cpDNA or cfDNA. This 23-gene panel shows promise for the non-invasive diagnosis and risk stratification of UBC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ward et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: